Latest stories on VTVT
vTv Therapeutics GAAP EPS of -$0.94 beats by $0.15
Seeking Alpha63 · neutralearnings
vTv Therapeutics Inc. (VTVT) files 8-K
SEC 8-K50 · neutralgeneral
vTv Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
StockTitan50 · neutralearnings
vTv Therapeutics Inc. (VTVT) Discusses Hypoglycemia Burden in Type 1 Diabetes and Cadisegliatin Phase 3 Program - Slideshow
Seeking Alpha53 · neutralproduct/pr
vTv Therapeutics Inc. (VTVT) Discusses Hypoglycemia Burden in Type 1 Diabetes and Cadisegliatin Phase 3 Program Transcript
Seeking Alpha58 · neutralproduct/pr
vTv Therapeutics' sickle cell asset HPPD gains FDA orphan drug status
Seeking Alpha67 · bullishproduct/pr
vTv Therapeutics Announces FDA Orphan Drug Designation for HPPD in Sickle Cell Disease
StockTitan67 · bullishproduct/pr
vTv Therapeutics Inc. (VTVT) files 8-K
SEC 8-K50 · neutralgeneral
vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)
Business Insider63 · neutralproduct/pr
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
vTv Therapeutics to Participate in September Investor Conferences
GlobeNewswire56 · neutralgeneral
vTv Therapeutics initiated with an Outperform at LifeSci Capital
The Fly61 · neutralanalyst
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
vTv Therapeutics Inc. (VTVT) files 8-K
SEC 8-K50 · neutralgeneral
vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
StockTitan56 · neutralearnings
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | VTVT Stock News
StockTitan50 · neutralgeneral
vTv Therapeutics Inc. (VTVT) files 8-K
SEC 8-K50 · neutralgeneral
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | VTVT Stock News
StockTitan50 · neutralgeneral